CN114874921B - Aureobasidium pullulans from Antarctic source and application thereof - Google Patents
Aureobasidium pullulans from Antarctic source and application thereof Download PDFInfo
- Publication number
- CN114874921B CN114874921B CN202210625055.6A CN202210625055A CN114874921B CN 114874921 B CN114874921 B CN 114874921B CN 202210625055 A CN202210625055 A CN 202210625055A CN 114874921 B CN114874921 B CN 114874921B
- Authority
- CN
- China
- Prior art keywords
- aureobasidium pullulans
- product
- culture
- pearl
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000223678 Aureobasidium pullulans Species 0.000 title claims abstract description 55
- 238000000855 fermentation Methods 0.000 claims abstract description 28
- 230000004151 fermentation Effects 0.000 claims abstract description 28
- 239000002537 cosmetic Substances 0.000 claims abstract description 12
- 238000004321 preservation Methods 0.000 claims abstract description 12
- 239000000047 product Substances 0.000 claims description 34
- 239000001963 growth medium Substances 0.000 claims description 21
- 230000003078 antioxidant effect Effects 0.000 claims description 13
- 238000012258 culturing Methods 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 230000006870 function Effects 0.000 claims description 11
- 238000009630 liquid culture Methods 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000002609 medium Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 230000014759 maintenance of location Effects 0.000 claims description 7
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000007222 ypd medium Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 1
- 239000008176 lyophilized powder Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 230000006378 damage Effects 0.000 abstract description 6
- 244000005700 microbiome Species 0.000 abstract description 5
- 230000006750 UV protection Effects 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 230000035699 permeability Effects 0.000 abstract description 3
- 206010042496 Sunburn Diseases 0.000 abstract 1
- 230000003405 preventing effect Effects 0.000 abstract 1
- 230000036561 sun exposure Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 16
- 150000004676 glycans Chemical class 0.000 description 13
- 229920001282 polysaccharide Polymers 0.000 description 13
- 239000005017 polysaccharide Substances 0.000 description 13
- 150000003254 radicals Chemical class 0.000 description 12
- 230000004083 survival effect Effects 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 238000011218 seed culture Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 230000003204 osmotic effect Effects 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 235000010633 broth Nutrition 0.000 description 6
- 238000007865 diluting Methods 0.000 description 6
- 238000009629 microbiological culture Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 241001052560 Thallis Species 0.000 description 4
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000006851 antioxidant defense Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000006783 corn meal agar Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- -1 oxygen radicals Chemical class 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- KEQXNNJHMWSZHK-UHFFFAOYSA-L 1,3,2,4$l^{2}-dioxathiaplumbetane 2,2-dioxide Chemical compound [Pb+2].[O-]S([O-])(=O)=O KEQXNNJHMWSZHK-UHFFFAOYSA-L 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 240000006568 Lathyrus odoratus Species 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 241000382362 Persicaria tinctoria Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008049 biological aging Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses Aureobasidium pullulans from Antarctic sources and application thereof, relates to the field of microorganisms, and provides Aureobasidium pullulans with a preservation number of CGMCC No.21195, wherein the strain has good cold resistance, permeability resistance, UV resistance and other aspects, and a fermentation product of the strain has good activities of resisting oxidation and UV damage, and can have the effects of resisting oxidation, aging, preventing sunburn and repairing after sun exposure when applied to cosmetics.
Description
Technical Field
The invention relates to the field of microorganisms, in particular to Aureobasidium pullulans from south pole sources and application thereof.
Background
One of the causes of skin aging is free radical aging, and the theory suggests that excessive free radicals are a significant cause of biological aging. According to this theory, excessive active oxygen radicals in the body react with unsaturated fatty acids to produce malondialdehyde, which reacts with proteins on cell membranes to produce brown pigment, which precipitates on the skin to form various color spots. The excessive free radicals can also cause collagen fibers and elastic fibers in the skin to crosslink, denature, become brittle and lose elasticity, and when the moisture of the skin is insufficient, the elastic fibers are easily broken, so that skin aging phenomena such as dark lines, fine lines, wrinkles and the like occur. In addition, the ion radiation in the environment and environmental pollutants such as air pollution and chemicals also cause the continuous generation of free radicals in living organisms. For example, ultraviolet light stimulates fibroblasts and granosomes in the dermis of the skin, releasing superoxide anions, which are converted to other more damaging free radicals. Although the human body has an antioxidant defense system capable of maintaining a balance between oxidation and antioxidation to slow down the generation of active oxygen and free radicals, if the human body is excessively exposed to sunlight for a long period of time, the free radicals generated in a large amount in the human body may cause a decrease in the antioxidant defense ability of the skin, causing skin damage such as photoaging, skin wrinkles, skin immunity disorders, etc. Currently, antioxidants for scavenging free radicals in living bodies such as vitamin E and vitamin C are known, and antioxidants of plant origin such as citrus fruit extracts and the like are reported.
Another important cause of skin aging is photoaging, which causes an increase in the activity of skin elastase due to Ultraviolet (UV) exposure. At present, plant-derived anti-aging actives are known as Polygonum tinctorium, sweet pea, etc.
Although anti-aging substances derived from microorganisms having the effects of scavenging free radicals and resisting aging are gaining attention in the skin care industry, microorganisms having a high ability to resist ultraviolet rays, a high polysaccharide content, or a high antioxidant activity are still lacking.
In view of this, the present invention has been made.
Disclosure of Invention
The invention aims to provide aureobasidium pullulans from south pole sources and application thereof.
The invention is realized in the following way:
in a first aspect, an embodiment of the present invention provides a aureobasidium pullulans, which has a preservation number of CGMCC No.21195.
In a second aspect, embodiments of the present invention provide a method for producing Aureobasidium pullulans, comprising culturing Aureobasidium pullulans as described in the previous embodiments.
In a third aspect, an embodiment of the present invention provides a microbial agent, which includes aureobasidium pullulans as described in the previous embodiment.
In a fourth aspect, embodiments of the present invention provide a ferment obtained from the Aureobasidium pullulans fermentation culture described in the previous embodiments.
In a fifth aspect, embodiments of the present invention also provide a product having a specific function, the product comprising at least one of Aureobasidium pullulans as described in the previous embodiments and ferments as described in the previous embodiments; the specific functions include: at least one of moisturizing, anti-ultraviolet and antioxidant activity.
In a sixth aspect, embodiments of the present invention provide the use of Aureobasidium pullulans as described in the previous embodiments or of a ferment as described in the previous embodiments for the preparation of a product having specific functions, including: at least one of moisturizing, anti-ultraviolet and antioxidant activity.
The invention has the following beneficial effects:
aiming at the defects of the existing microorganisms with strong ultraviolet resistance, high polysaccharide content and strong antioxidant activity, the embodiment of the invention provides the aureobasidium pullulans with the preservation number of CGMCC No.21195, the strain has good performance in cold resistance, permeability resistance, UV resistance and other aspects, and the fermentation product has good skin care effect of resisting UV damage.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings that are needed in the embodiments will be briefly described below, it being understood that the following drawings only illustrate some embodiments of the present invention and therefore should not be considered as limiting the scope, and other related drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
FIG. 1 shows the strain morphology of Aureobasidium pullulans OSM-NJ01-Gly-1-01 on PDA medium and under microscope;
FIG. 2 shows strain viability in an ultraviolet radiation environment;
FIG. 3 shows strain viability in a low temperature environment;
FIG. 4 is a graph of strain growth in a hypertonic environment;
FIG. 5 shows crude polysaccharide from different strains compared to the quality of the bacteria.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention more clear, the technical solutions of the embodiments of the present invention will be clearly and completely described below. The specific conditions are not noted in the examples and are carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or apparatus used were conventional products commercially available without the manufacturer's attention.
The embodiment of the invention provides Aureobasidium pullulans, which has a preservation number of CGMCC No.21195.
And selecting Aureobasidium pullulans separated from Antarctic soil to obtain Aureobasidium pullulans CGMCC No.21195. The Aureobasidium pullulans CGMCC No.21195 grows well in a PDA liquid culture medium and has the characteristics of strong ultraviolet resistance, high polysaccharide content and strong antioxidant activity.
Biological material preservation information: the Aureobasidium pullulans (Aureobasidium pullulans) of the invention are preserved in China general microbiological culture collection center (China General Microbiological Culture Collection Center, CGMCC) in 11/16/2020, and have the preservation addresses: the microbiological institute of China, national academy of sciences, no. 3, beijing, chaoyang district, north Chen, west way, and post code: 100101, the preservation number is CGMCC No.21195, the culture name is Aureobasidium pullulans OSM-NJ01-Gly-1-01, and the classification name is Aureobasidium pullulans OSM-NJ01-Gly-1-01.
In some embodiments, the morphological features of the aureobasidium pullulans include: culturing in malt juice liquid culture medium at 24-26 deg.c for 2-4 days (preferably 3 days) to form precipitate in the form of at least one of oval, elliptic and oblong with cell size of (3.0-5.7) × (4.7-10.0) microns; culturing wort agar inclined plane at 24-26 ℃, wherein the colony is cheese-shaped, milk white, wet and smooth in surface and glossy, and the colony turns black after two weeks; cultured in corn meal agar Dalmau plates, no pseudohyphae were produced.
In some embodiments, the physiological and biochemical characteristics of the aureobasidium pullulans include: the carbon source which can be utilized by the aureobasidium pullulans comprises at least one of glucose, sucrose, maltose, galactose, raffinose and L-sorbose; non-fermentation of at least one of glucose, galactose, sucrose, lactose, maltose and raffinose; the different carbon sources include at least one of L-rhamnose, glycerol, galactitol, lactose, D-sorbitol, and ribitol.
The invention also provides a production method of the aureobasidium pullulans, which comprises the step of culturing the aureobasidium pullulans in any previous embodiment.
Wherein the culture medium is a culture medium conventional in the art, and can grow the Aureobasidium pullulans CGMCC No.21195, preferably a PDA liquid culture medium, a YPD culture medium or a GMMY culture medium.
The PDA liquid medium is a PDA liquid medium conventional in the art, and preferably comprises 5g/L potato starch, 15g/L glucose and 10g/L peptone. The temperature of the culture is the temperature conventional in the art, and the Aureobasidium pullulans CGMCC No.21195 can be grown, preferably 15-35 ℃, and more preferably 28 ℃. The time for the cultivation is a time conventional in the art, preferably 2 to 7 days, more preferably 2 days. The strain morphology of Aureobasidium pullulans OSM-NJ01-Gly-1-01 on PDA medium and the morphology under microscope are shown in FIG. 1.
Preferably, the method further comprises the step of seed culture by using a seed culture medium before the culture. The seed culture is conventional in the art. The seed culture medium is a seed culture medium conventional in the art, preferably PDA liquid culture medium. The time for the seed culture is a time conventional in the art, preferably 48 to 60 hours, more preferably 48 hours. The temperature of the seed culture is a temperature conventional in the art, preferably 28 to 30 ℃. The seed culture is inoculated in an amount conventional in the art, preferably 5%, the percentages being by volume.
The embodiment of the invention also provides a microbial agent, which comprises the aureobasidium pullulans according to any of the previous embodiments.
The embodiment of the invention also provides a ferment obtained by fermenting and culturing the aureobasidium pullulans in any embodiment.
In some embodiments, the fermenting comprises: inoculating the seed solution of Aureobasidium pullulans into a liquid culture medium containing pearl powder for culture to obtain a pearl fermentation product.
In some embodiments, the seed fluid is inoculated in an amount of: the volume fraction may be 1% -5%, specifically, may be any one or any range between two of 1%, 2%, 3%, 4% and 5%.
In some embodiments, the mass fraction of the pearl powder in the liquid culture medium is 0.01% -3%, and specifically may be any one or any range between two of 0.01%, 0.05%, 0.1%, 0.5%, 1%, 2% and 3%.
In some embodiments, after inoculation, the culture is performed at 28-30℃for 3-7 days to obtain a culture broth. The culture time can be specifically any one or any two of 3 days, 4 days, 5 days, 6 days and 7 days; the specific temperature of the culture may be in the range of 28℃or 29℃or 30℃or any range between any two.
In some embodiments, the fermenting further comprises: centrifuging the culture solution, collecting supernatant, filtering, and sterilizing to obtain the pearl fermentation product.
In some embodiments, the centrifugation conditions are: 4-10 ℃, 3000-10000 rpm, 1-10 min.
Embodiments of the present invention provide a product having a specific function, the product comprising at least one of Aureobasidium pullulans as described in the previous embodiments and fermentates as described in the previous embodiments; the specific functions include: at least one of moisturizing, anti-ultraviolet and antioxidant activity.
In some embodiments, the type of product is any one of a skin external agent, a cosmetic, a health product, and a pharmaceutical. The external preparation for skin may be a general concept of all components commonly used outside the skin, and may be, for example, cosmetics or medicines. The cosmetic can be basic cosmetic, facial make-up cosmetic, eye cosmetic, head care product, body cosmetic, etc., and the dosage form is not particularly limited, and can be reasonably selected according to different purposes.
In some embodiments, the product is in the form of any one of a gas, a solid, and a liquid. Such product forms include, but are not limited to, aerosol sprays, creams, emulsions, solids, liquids, dispersions, foams, gels, lotions, mousses, ointments, powders, patches, pomades, hand pump sprays, sticks, masks and wet wipes. The skin external preparation of the present invention may be a cosmetic, dermatological or pharmaceutical topical application product, and the preparation method thereof may be a conventional preparation method in the art, as is well known.
In some embodiments, the product may further comprise a carrier, which is a pharmaceutically acceptable carrier conventional in the art, preferably one or more of a preservative, a fragrance, a hydrophilic active agent, and a lipophilic active agent. The pharmaceutically acceptable carrier is present in an amount conventional in the art.
In some embodiments, the skin external preparation may further comprise one or more of the following ingredients: a lipid-forming agent, a dispersant, a viscosity modifier, a solvent, a thickener, a whitening agent, a skin protectant, a chelating agent, a spot-removing agent, a skin feel modifier, an emollient, a cleanser, a moisturizer, a sunscreen agent, a pH modifier, a suspending agent, a solubilizer, a buffer, a reducing agent, an emulsifier, an emulsion stabilizer, a photostabilizer, a cooling agent, a surface modifier, an antioxidant, a film former, or any combination thereof. The amounts of these ingredients may be those conventional in the art.
In some embodiments, the specific function further comprises a high yield polysaccharide.
On the basis of the common general knowledge in the field, the above preferred or optional conditions can be arbitrarily combined to obtain the preferred examples of the invention.
An embodiment of the present invention provides the use of Aureobasidium pullulans as described in any of the preceding embodiments or of a ferment as described in any of the preceding embodiments for the preparation of a product having specific functions, including: at least one of anti-ultraviolet and anti-oxidation activity.
It will be appreciated that the specific reference to the product in the application may be the same as that described in any of the foregoing embodiments, and will not be repeated.
The features and capabilities of the present invention are described in further detail below in connection with the examples.
Example 1
27 strains were obtained by separation from a soil sample in the intertidal zone (sample number: S02; collection site: south Philippines peninsula region; longitude 058° 57.8225'; latitude 62° 13.0705'; sampling depth: 0 m; weight: 100g; sampling time: 10 th 1 st 2008), one of the strains NJ1P3 (NJ 1P3 is the strain number, the same applies hereinafter) was identified as Aureobasidium pullulans (Aureobasidium pullulans) after separation, and the strain was preserved in China general microbiological culture collection center (China General Microbiological Culture Collection Center, CGMCC) at 11 th month 16 in 2020, the preservation address: the institute of science and microbiology, post code: 100101, the preservation number is CGMCC No.21195, the culture name is Aureobasidium pullulans OSM-NJ01-Gly-1-01, and the classification name is Aureobasidium pullulans OSM-NJ01-Gly-1-01.
The control strain is Aureobasidium pullulans isolated from soil collected from Yunnan, and the strain number is: YN128-1 isolated from Aureobasidium pullulans obtained from Gansu Compositae leaves, strain number: 23-1, which belongs to the extreme climate environment with high altitude, strong ultraviolet radiation and large temperature difference.
(1) Survival test in Ultraviolet (UV) environments
Strain activation: the strain stored at 4℃was transferred to a new slant in an ultra clean bench and cultured at 28℃for two days. Strain culture: colonies on the activated slants were scraped into 50mL YPD medium (10 g/L yeast extract, 20g/L glucose, 20g/L peptone) and cultured on a shaker for 48 hours (28 ℃, 150 rpm).
And (3) obtaining thalli: 10mL of the culture broth was centrifuged (8000 rpm, 10 min) for two days, the supernatant was discarded, 10mL of sterile water was added, and the cells were resuspended.
Ultraviolet irradiation: the obtained thallus suspension is subjected to ultraviolet irradiation for 0s and 20min in a biosafety cabinet (pre-ultraviolet preheating for 10 min), and the thallus suspension is fully mixed in a flat plate after the ultraviolet irradiation and diluted for 10min -3 After that, 20. Mu.L was counted for PDA coating, three replicates each, incubated at 28℃for 48 hours in the absence of light.
Survival rate calculation: and counting the plates after the plate culture is finished, and calculating according to the following formula to obtain the survival rate.
X=1- (a-B)/a×100%; wherein, X: survival rate; a: colony number of 0s plate growth; b: colony count was grown on plates for 20 min.
After 20 minutes of ultraviolet treatment of bacterial suspensions of Aureobasidium pullulans from Antarctica, yunnan and Gansu, the survival rate of NJ1P3 is higher compared with that of control strains YN128-1 and 23-1, indicating that the NJ1P3 has stronger resistance to strong ultraviolet radiation. The results are shown in FIG. 2.
(2) Low temperature survival rate test
Strain activation: strains stored at 4℃were inoculated on a new PDA slope in an ultra clean bench and incubated at 28℃for two days.
Strain culture: colonies on the activated slants were scraped into 50mL YPD medium (10 g/L yeast extract, 20g/L glucose, 20g/L peptone) and cultured on a shaker for 48 hours (28 ℃, 150 rpm).
And (3) obtaining thalli: 10mL of the culture was centrifuged (8000 rpm, 10 min), the supernatant was discarded, 10mL of sterile water was added, and the cells were resuspended.
And (3) low-temperature treatment: diluting 1mL of bacterial liquid to 10 -3 The plates were coated. Placing the bacterial suspension in a refrigerator at-20deg.C for one week, and diluting for 10 times after low temperature treatment -3 mu.L of the cells were PDA-coated, three replicates were made for each strain, and incubated at 28℃for 48 hours.
Survival rate calculation: after the plates had grown to colonies, counts were made and calculated according to the following formula.
X=1- (a-B)/a×100%; wherein, X: survival rate; a: the number of colonies grown on the plate prior to the low temperature treatment; b: number of colonies grown on plates after-20 ℃.
The two strains were placed in a refrigerator at-20℃and after one week, PDA plate coating was performed, colonies growing on the plates were counted, and survival rates were calculated. The result shows that the survival rate of the NJ1P3 under the condition of-20 ℃ is higher than that of the control strains YN128-1 and 23-1, and the NJ1P3 has stronger capability of resisting the low-temperature environment. As shown in fig. 3.
(3) High permeability survival test
Strain activation: strains stored at 4℃were inoculated on a new PDA slope in an ultra clean bench and incubated at 28℃for two days.
Strain culture: colonies on the activated slants were scraped into 50mL YPD medium (10 g/L yeast extract, 20g/L glucose, 20g/L peptone) and cultured on a shaker for 48 hours (28 ℃, 150 rpm).
And (3) obtaining thalli: 10mL of the culture was centrifuged (8000 rpm, 10 min), the supernatant was discarded, 10mL of sterile water was added, and the cells were resuspended.
Culturing in a hypertonic environment: diluting the bacterial suspension 10 -3 Preparing 15% NaCl mother liquor, using YNB medium (67 g/L Bacto Yeast Nitrogen Base, 50g/L glucose) diluted NaCl stock to 0%, 5% and 11% with osmotic pressures near 0mOsm, 2000mOsm and 3142mOsm, respectively (as a comparison, the cell osmotic pressure was about 300mOsm, whereas the normal seawater osmotic pressure was 1000 mOsm). 180 mu L of YNB culture medium and 20 mu L of bacterial suspension are added into a 96-well plate, an enzyme-labeled instrument (Texan Spark) is placed for culture, OD600 is measured every other hour, a growth curve is drawn until reaching a stationary phase, and the growth condition of the strain in different osmotic pressure environments is measured.
Studies have shown that with osmotic pressures approaching 0mOsm, NJ1P3 grew better than YN128-1 and 23-1 and reached equilibrium at around 8 days. With the increase of osmotic pressure, the growth of three strains gradually weakens, but the growth condition of NJ1P3 is always higher than YN128-1 and YN 23-1, and the time for reaching the equilibrium period is also prolonged, which shows that the hypertonic environment can influence the growth of the strains, but the NJ1P3 has stronger resistance to the hypertonic environment. The results are shown in FIG. 4, with the environmental osmotic pressures approaching 0mOsm, 2000mOsm and 3142mOsm from top to bottom.
Example 2
Morphological and cultural characteristics of strains.
The NJ1P3 strain was cultured in malt liquor liquid medium at 25℃for three days, and the cell size (3.0 to 5.7) × (4.7 to 10.0) μm, oval, elliptical, oblong form a precipitate. The wort agar was incubated at 25℃with cheese-like colonies, milky white, moist and smooth surface, glossy and after two weeks the colonies turned black. Corn meal agar Dalmau plates were cultured without producing false hyphae. The determined NJ1P3 strain D1/D2 sequence (shown as SEQ ID No. 1) is subjected to 26S rDNA sequence Blast comparison with NCBI database, has homology of more than 99% with Aureobasidium pullulans strain, has very similar genetic relationship, and is determined to be Aureobasidium pullulans by combining with morphological characteristics of the strain.
The sequence shown in SEQ ID No.1 is as follows:
gcggacctcagtcccggctggccgtattacacactgggctataacacctccaccgaagtggaggccacatt cccagagcctttatccggccgccgaaactgatgctggcctgtccaaactgagtaaaccggtcagaagaccggcc gaacagtttaaacaagtctgattgcaagcgcttccctttcaacaatttcacgtgctttttaactctctttccaaagtgctttt catctttcgatcactctacttgtgcgctatcggtctctcgccaatatttagctttagaagaaatttacctcccatttagagc tgcattcccaaacaactcgactcgtcgaaggagctttacataggttaacatttccagtcacatacgggattctcaccct ctatgacgtcctgttccaaggaacttagactggcgttttacccaaagcatcctctacaaattacaatgcgaacccgaa ggctagctttcaaatttgagctgttgccgcttcactcgccgttactagggcaatccctgttggtttcttttcctccgcttat tgatatgcttaagttcagcgggtatccctacctgatccgaggtcaacctagaaaaataaaggtttcaatcggcagagt tcctctcctttgacagacgttcgaataaattctactacgcctaaagccggagtggcctcgccgaggtctttaaggcgc gcccaactaaggacg。
example 3
Physiological and biochemical characteristics of the strain.
The strain was subjected to physiological and biochemical characterization by reference to Zu Refu, hu Baolong, zhou Deqing, course of microbiology experiment (1993 of the university of double denier press).
As a result, it was found that glucose, sucrose, maltose, galactose, raffinose, L-sorbose and the like as carbon sources can be utilized for the NJ1P3 strain; non-fermentation glucose, galactose, sucrose, lactose, maltose, raffinose; different carbon sources L-rhamnose, glycerol, galactitol, lactose, D-sorbitol and ribitol.
The NJ1P3 strain is preserved in China general microbiological culture collection center (China General Microbiological Culture Collection Center, CGMCC) at 11 and 16 months in 2020, and the preservation address is: the institute of science and microbiology, post code: 100101, the preservation number is CGMCC No.21195, the culture name is Aureobasidium pullulans OSM-NJ01-Gly-1-01, and the classification name is Aureobasidium pullulans OSM-NJ01-Gly-1-01.
Example 4
Culturing the strain.
Inoculating the NJ1P3 strain into a PDA liquid culture medium, and culturing at 28 ℃ for 48 hours to obtain seed liquid;
5% (v/v) seed solution was inoculated into PDA liquid medium, shaking-cultured at 28℃and 200rpm for 2 days.
Example 5
And (3) preparing the pearl fermentation product.
Respectively inoculating the strains YN128-1 and NJ1P3 into a PDA liquid culture medium, and culturing at 28 ℃ for 48 hours to obtain seed liquid;
inoculating 5% (v/v) seed solution into PDA liquid culture medium containing 1% (w/w) pearl powder, shake culturing at 28deg.C at 200rpm for 5 days to obtain culture solution;
centrifuging the culture solution at 8deg.C and 8000rpm for 5 min, collecting supernatant, and filtering for sterilizing to obtain pearl fermentation product.
Example 6
And detecting the polysaccharide content and the molecular weight of the pearl fermentation product.
Fermenting and culturing the two strains to obtain crude polysaccharide, drying thalli and the crude polysaccharide, and weighing. The result shows that the quality of the strain NJ1P3 and the quality of crude polysaccharide are higher than those of YN128-1, and the growth activity of the strain NJ1P3 is higher than that of YN128-1, and the polysaccharide content in the fermentation broth is higher than that of the control strain YN128-1. The results are shown in FIG. 5.
After deproteinizing the crude polysaccharide obtained by fermentation, the molecular weight is measured by a field flow separation technique, and the molecular weight distribution and average molecular weight of the polysaccharide produced by NJ1P3 fermentation are measured. The results are shown in Table 1.
TABLE 1 molecular weight ranges of polysaccharide in fermentation broths
Example 7
And (5) detecting the antioxidant activity of the pearl fermentation product.
Taking Vc as a positive control, taking 1.5mg of Vc, uniformly mixing and dissolving with 1mL of distilled water to obtain a Vc stock solution of 1.5mg/mL, taking 100 mu L of the Vc stock solution, diluting to 30mL to obtain a Vc solution with the concentration of 0.005mg/mL, and obtaining the final concentration of the Vc solution in the reaction of 2.5ppm.
A fermentation sample was prepared as in example 5, and its antioxidant activity for scavenging free radicals was measured by DPPH method.
Diluting each 1mL of test sample with absolute ethyl alcohol for 2.5 times, centrifuging at 3800rpm for 12min, taking supernatant, diluting each 2mL of the supernatant with ultrapure water to 4mL, and obtaining a sample solution with the final concentration of 10%;
2mL of the sample solution was taken and put into a test tube, and 2X 10 was added -4 2mL of mol/L DPPH ethanol solution, uniformly mixing, carrying out light-shielding reaction for 30min at 25 ℃, and measuring absorbance A517 at 517 nm; the clearance was calculated according to the following formula, and the greater the clearance, the stronger the antioxidant capacity, and the results are shown in the following table.
Clearance I (%) = [1- (T-T0)/(C-C0) ] ×100%
Wherein: t: absorbance of 2mL sample solution plus 2mL DPPH solution;
t0: absorbance of 2mL of the sample solution plus 2mL of absolute ethanol solution;
c0: absorbance of 2mL water plus 2mL absolute ethanol;
c: absorbance of 2mL DPPH solution plus 2mL ultrapure water.
Table 2 free radical clearance of different species fermentation broths (%, n=2)
Sample of | Vc | YN128-1 pearl ferment | NJ1P3 pearl fermentation product |
Clearance rate of | 23.75 | 22.89 | 56.07 |
As shown in the table above, the free radical clearance of YN128 pearl ferment is far lower than that of NJ1P3 pearl ferment, and Antarctic bacteria fermentation liquor has stronger antioxidant activity.
Example 8
And testing the activity of the pearl ferment against ultraviolet injury.
A fermentation sample was prepared as in example 5.
The measuring steps are as follows:
inoculating 5000 HaCAT cells in 96-well plate, preparing sample according to the following table when cell fusion degree is about 80%, treating cells, and placing CO 2 The incubator continues to incubate. After 24h, cells were irradiated with UVA or UVB and the non-irradiated group was set as a blank. Immediately sucking the culture medium after UVA irradiation, adding 0.5mg/mL MTT, adding DMSO after 3 hours to extract formazan, and detecting absorbance at 560nm by using an enzyme-labeling instrument; after UVB irradiation, CO is put in 2 The incubator continues to incubate. After 24h, the medium was aspirated, 0.5mg/mL MTT was added, and after 3h, formazan was extracted with DMSO and absorbance at 560nm was measured using a microplate reader.
The results are shown in tables 3 and 4, which demonstrate that the pearl fermentate helps the skin to resist UVA and UVB damage and the effect is similar to the positive control 0.005% Vc effect.
TABLE 3 Activity test of pearl fermentate against UVA injury
TABLE 4 Activity test of pearl fermentate against UVB injury
Example 9
And (5) testing the moisturizing activity of the pearl fermentation product.
A fermentation sample was prepared as in example 5 and tested for moisture retention of a 6% sodium hyaluronate solution and a pearl ferment (5.95% solids) by in vitro weighing.
Accurately weighing 2.5g of sample and sodium hyaluronate solution, placing in a dryer (placing silica gel desiccant), and weighing the mass of the sample after 2, 4, 6, 8 and 24 hours at regular time. The results are shown in Table 5.
TABLE 5 moisture retention of pearl fermentate
Time (h) | HA moisture retention (%) | Moisture retention of pearl ferment (%) |
2 | 76.25 | 78.57 |
4 | 73.73 | 76.19 |
6 | 71.00 | 73.53 |
8 | 68.66 | 70.80 |
24 | 49.48 | 52.48 |
As can be seen from Table 5, the sodium hyaluronate solution with a higher moisture retention rate than 6% for the pearl fermentate at each time, demonstrated better moisture retention of the Antarctic bacteria broth.
Example 10
Essence containing pearl ferment is provided.
The essence of example 10 was prepared according to the preparation method of the lotion and the composition of table 6, which are conventional in the art.
TABLE 6 Table of essential components
Example 11
Testing stability of essence containing pearl ferment.
The essence prepared in example 10 was subjected to stability tests of heat resistance, cold resistance, alternation, light irradiation, etc. Wherein, the heat-resistant test conditions are: 45+/-1 ℃, keeping constant temperature and avoiding light for 7 days;
the cold resistance test conditions are as follows: -20+/-1 ℃, keeping the temperature away from light, and 7 days;
the alternating test conditions were: transferring from-20deg.C constant temperature for 3.5 days to 45deg.C constant temperature for 3.5 days, and keeping away from light;
the illumination test conditions are as follows: illumination constant temperature and humidity test box (1.47 x 10) 6 Lux·hr),7d。
The test results are shown in the following table.
Table 7 stability test
The results show that the cosmetics prepared from the pearl fermentation product have excellent stability.
The above description is only of the preferred embodiments of the present invention and is not intended to limit the present invention, but various modifications and variations can be made to the present invention by those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Sequence listing
<110> Oshi Diffuse biological Co.Ltd
ZHEJIANG OSM GROUP Co.,Ltd.
<120> Aureobasidium pullulans of Antarctic origin and use thereof
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 720
<212> DNA
<213> Aureobasidium pullulans strain
<400> 1
gcggacctca gtcccggctg gccgtattac acactgggct ataacacctc caccgaagtg 60
gaggccacat tcccagagcc tttatccggc cgccgaaact gatgctggcc tgtccaaact 120
gagtaaaccg gtcagaagac cggccgaaca gtttaaacaa gtctgattgc aagcgcttcc 180
ctttcaacaa tttcacgtgc tttttaactc tctttccaaa gtgcttttca tctttcgatc 240
actctacttg tgcgctatcg gtctctcgcc aatatttagc tttagaagaa atttacctcc 300
catttagagc tgcattccca aacaactcga ctcgtcgaag gagctttaca taggttaaca 360
tttccagtca catacgggat tctcaccctc tatgacgtcc tgttccaagg aacttagact 420
ggcgttttac ccaaagcatc ctctacaaat tacaatgcga acccgaaggc tagctttcaa 480
atttgagctg ttgccgcttc actcgccgtt actagggcaa tccctgttgg tttcttttcc 540
tccgcttatt gatatgctta agttcagcgg gtatccctac ctgatccgag gtcaacctag 600
aaaaataaag gtttcaatcg gcagagttcc tctcctttga cagacgttcg aataaattct 660
actacgccta aagccggagt ggcctcgccg aggtctttaa ggcgcgccca actaaggacg 720
Claims (10)
1. Aureobasidium pullulans is characterized in that the preservation number is CGMCC No.21195.
2. A production method of aureobasidium pullulans, characterized in that it comprises culturing aureobasidium pullulans as defined in claim 1.
3. The method according to claim 2, wherein the culture medium used for the culture is at least one selected from the group consisting of PDA liquid medium, YPD medium and GMMY medium.
4. A production method according to claim 2 or 3, wherein the conditions of the cultivation are; 15-35 ℃ for 2-7 days.
5. A microbial agent comprising the aureobasidium pullulans as defined in claim 1.
6. A ferment obtained by fermentation culture of aureobasidium pullulans as defined in claim 1;
the fermentation comprises: inoculating the seed solution of Aureobasidium pullulans into a liquid culture medium containing pearl powder for culture to obtain a pearl fermentation product;
the inoculation amount of the seed liquid is as follows: 1% -5% of volume fraction;
the pearl powder comprises at least one of submicron pearl powder, water-soluble pearl powder and hydrolyzed pearl lyophilized powder;
the mass fraction of the pearl powder in the liquid culture medium is 1% -3%;
after inoculation, culturing for 3-7 days at the temperature of 28-30 ℃ to obtain a culture solution;
the fermentation further comprises: centrifuging the culture solution, taking supernatant, filtering and sterilizing to obtain a pearl fermentation product;
the centrifugation conditions are as follows: 4-10deg.C, 3000-10000 rpm, 1-10 min.
7. A product with specific functions, characterized in that it comprises a ferment according to claim 6; the specific functions are as follows: at least one of anti-ultraviolet, antioxidant activity and moisture retention;
the product is any one of external preparation for skin and cosmetic.
8. The product of claim 7, wherein the product is in any one of a gaseous state, a solid state, and a liquid state.
9. Use of a ferment according to claim 6 for the preparation of a product with a specific function, wherein the specific function is: at least one of moisturizing, anti-uv and anti-oxidant activity;
the product is any one of external preparation for skin and cosmetic.
10. The use according to claim 9, wherein the product is in the form of any one of a gas, a solid and a liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210625055.6A CN114874921B (en) | 2022-06-02 | 2022-06-02 | Aureobasidium pullulans from Antarctic source and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210625055.6A CN114874921B (en) | 2022-06-02 | 2022-06-02 | Aureobasidium pullulans from Antarctic source and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114874921A CN114874921A (en) | 2022-08-09 |
CN114874921B true CN114874921B (en) | 2024-02-13 |
Family
ID=82679535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210625055.6A Active CN114874921B (en) | 2022-06-02 | 2022-06-02 | Aureobasidium pullulans from Antarctic source and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114874921B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102994395A (en) * | 2012-10-15 | 2013-03-27 | 苏州大学 | Aureobasidium pullulans and application thereof |
CN107485598A (en) * | 2017-08-30 | 2017-12-19 | 广州市科能化妆品科研有限公司 | A kind of pearl toner of thickening certainly and preparation method thereof |
KR20190104956A (en) * | 2019-08-27 | 2019-09-11 | 주식회사 아리바이오 | Aureobasidium pullulans for highly producing melanin free beta-glucan and method for culturing |
-
2022
- 2022-06-02 CN CN202210625055.6A patent/CN114874921B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102994395A (en) * | 2012-10-15 | 2013-03-27 | 苏州大学 | Aureobasidium pullulans and application thereof |
CN107485598A (en) * | 2017-08-30 | 2017-12-19 | 广州市科能化妆品科研有限公司 | A kind of pearl toner of thickening certainly and preparation method thereof |
KR20190104956A (en) * | 2019-08-27 | 2019-09-11 | 주식회사 아리바이오 | Aureobasidium pullulans for highly producing melanin free beta-glucan and method for culturing |
Also Published As
Publication number | Publication date |
---|---|
CN114874921A (en) | 2022-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105647974B (en) | A kind of saccharomyces cerevisiae plant fermentation object and its application and skin preparations for extenal use | |
CN109321501B (en) | Paenibacillus strain for producing polysaccharide with post-basking repair effect and application thereof | |
CN115125153B (en) | Preparation method and application of galactose yeast-like bacteria fermentation product filtrate | |
CN106726949B (en) | Grape seed fermentation raw stock cosmetic and preparation method and application thereof | |
CN116019747B (en) | Preparation method of guava fermentation product, product and application thereof | |
CN105420132B (en) | A kind of saccharomyces cerevisiae and its preparing the application in skin preparations for extenal use | |
CN113476388A (en) | Bulbus Lilii fermented product for cosmetic and its preparation method | |
CN109939059B (en) | Rice germ five-bacterium fermentation slow-release cosmetic and preparation method and application thereof | |
CN112370390B (en) | Fermentation liquor for resisting aging, removing wrinkles and repairing skin barrier and preparation method thereof | |
CN114874921B (en) | Aureobasidium pullulans from Antarctic source and application thereof | |
CN109486712B (en) | Pseudomonas rouxii PYQ4 capable of highly yielding exopolysaccharides and preparation method and application of polysaccharides of pseudomonas rouxii PYQ4 | |
CN115927128B (en) | Transparent tremella fermentation product and preparation method and application thereof | |
CN115093985B (en) | Lactobacillus bifidus and fermentation method and application thereof | |
CN113041200B (en) | Cosmetic containing multiple fermentation liquor of custard apple and preparation method thereof | |
JP7026755B2 (en) | Fermented matsutake mushrooms, compositions and their use that repair hair damage and delay scalp aging | |
CN110638697B (en) | Preparation and application of ganoderma lucidum lactobacillus fermentation extract | |
CN113648262A (en) | Lily leaf and cherry fermented product for cosmetic and preparation method thereof | |
CN111407702A (en) | Skin-care face cream containing sophora flower and seaweed and preparation method of skin-care face cream | |
CN117625405A (en) | Aureobasidium pullulans and fermentation product and application thereof | |
CN115737478B (en) | Application of desert algae skin care raw material in preparation of skin soothing agent | |
TWI802179B (en) | Cactus fermentate, topical skin composition including the same with effects of moistening, redness relieving and line refining and use thereof | |
CN117925731B (en) | Galactose yeast-like fungus centella asiatica fermentation product and preparation method and application thereof | |
CN114392210B (en) | Composition with effects of resisting aging, reducing wrinkle and improving skin luster and preparation method thereof | |
CN115154389A (en) | A fermented product | |
CN115192495A (en) | Coffee composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230117 Address after: 313000 No. 99, Zhenzhu street, Moganshan high tech Industrial Development Zone, Huzhou City, Zhejiang Province Applicant after: OSMUN BIOLOGICAL Co.,Ltd. Address before: 313000 No. 99, Zhenzhu street, Moganshan high tech Industrial Development Zone, Huzhou City, Zhejiang Province Applicant before: OSMUN BIOLOGICAL Co.,Ltd. Applicant before: Zhejiang OSM Group Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |